News

TAVR, Henry Ford Hospital, O'Neill, Greenbaum

Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers a new business opportunity for hospitals that begin a program. The technology...

University of Michigan, heart defect, baby, screening test

Thanks to a two-minute newborn screening test designed to help detect heart defects, a Michigan couple was made aware of their newborn daughter’s unexpected heart defect. The test is now a...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Corevalve, valve sizes

Medtronic announced CE (Conformité Européene) mark for the 26 and 29mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic...

Heart failure, MitraClip, International Symposium on Endovascular Therapy

A minimally invasive procedure to repair severe mitral valve regurgitation by clipping together the valve’s leaflets can improve function and quality of life and reduce the risk of hospitalization...

Stem Cell Therapy, Congenital heart, clinical trial/study

Researchers at Okayama University and Okayama University Hospital show that children suffering from a condition known as hypoplastic left heart syndrome experienced some improvement in cardiac...

Clinical trial/Study, Heart Valve Repair, CoreValve System

Medtronic revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared...

Neovasc Inc. has commenced a public offering in the United States of 8 million shares of the company to raise money for upcoming U.S. clinical trials and development of its transcatheter mitral...

Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR

Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of InterValve Inc.'s V8 Aortic Valvuloplasty Balloon Catheter.

Melody valve, FDA approval, PMA, pulonary valve

The U.S. Food and Drug Administration (FDA) has granted approval of Medtronic’s premarket approval application (PMA) for the Melody Transcatheter Pulmonary Valve (TPV) and its Ensemble...

FEops, TAVIguide, Series A financing, navigation, advanced visualization

FEops announced the closing of a €1.3 million (~$1.9 million USD) series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used to support the launch of FEops’...

Tennessee, Knoxville, heart valve, tissue engineered, calcification proof

There could soon be new hope for those facing one of humanity's biggest health issues, thanks to research from the University of Tennessee Knoxville College of Engineering.

CT systems, CT angiography, FFR Catheters, Direct Flow Medical Transcatheter

Direct Flow Medical Inc. announced the closing of a new round of financing for the company totaling $32 million. 

Transcatheter Technologies GmbH has announced that it is expanding its product family to include Tresillo, a transcatheter mitral valve implantation (TMVI) version. 

Minneapolis Heart Institute Foundation (MHIF) researchers have performed two implants of the Lotus Cardiac Valve System as part of the REPRISE III clinical trial. 

Sorin Group, Memo 3-D ReChord, annuloplasty ring, mitral valve repair

Sorin Group announced U.S. Food and Drug Administration (FDA) clearance for Memo 3-D ReChord, a semi-rigid annuloplasty ring for mitral valve repair.

REPRISE II trial, Lotus Valve System, Boston Scientific, one year data

New data from the Boston Scientific clinical trial program of the Lotus Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic...

Innovative Cardiovascular Solutions LLC has completed a Class A Unit financing totaling $5 million to fund its Emblok Embolic Protection Catheter. 

Heart valve repair, Trinity Transapical TAVI system

Transcatheter Technologies GmbH announced that it has expanded the Trinity technology platform to include a transfemoral version.

After watching his father die from heart valve disease, a mechanical engineer used his expertise in fluid dynamics to develop a first-of-its-kind procedure to replace leaking or regurgitating...